| |
| |
|
| Insider
Information: |
Gad Thomas |
| Relationship: |
CHIEF BUSINESS OFFICER... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
158,700 |
|
|
Indirect Shares
|
292,681 |
|
|
| Direct
Value |
$1,947,249 |
|
|
|
Indirect Value
|
$3,591,196 |
|
|
| Total
Shares |
451,381 |
|
|
| Total
Value |
$5,538,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
27
|
|
Stock
price went up :
|
0
|
14
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.1
|
| Percentage
Gain/Loss : |
0.0%
|
 471.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Y-Mabs Therapeutics Inc |
YMAB |
CHIEF BUSINESS OFFICER... |
2024-05-23 |
158,700 |
2024-05-23 |
292,681 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YMAB |
Y-Mabs Therapeutics Inc |
CHIEF BUSINESS OFFICER |
• • – |
2024-05-23 |
4 |
S |
$13.00 |
$95,563 |
I/I |
(7,351) |
232,681 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
CHIEF BUSINESS OFFICER |
• • – |
2024-05-21 |
4 |
S |
$12.00 |
$300,000 |
I/I |
(25,000) |
240,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
CHIEF BUSINESS OFFICER |
• • – |
2024-03-05 |
4 |
S |
$16.44 |
$64,116 |
D/D |
(3,900) |
158,700 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
CHIEF BUSINESS OFFICER |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,100 |
162,600 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-12-21 |
4 |
OE |
$2.00 |
$100,000 |
D/D |
50,000 |
140,500 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-12-15 |
4 |
S |
$6.61 |
$330,500 |
I/I |
(50,000) |
265,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-12-14 |
4 |
S |
$6.83 |
$341,500 |
I/I |
(50,000) |
315,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-12-13 |
4 |
S |
$6.58 |
$329,000 |
I/I |
(50,000) |
365,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-11-21 |
4 |
S |
$5.31 |
$397,988 |
I/I |
(75,000) |
415,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
Chief Business Officer |
• • – |
2023-11-20 |
4 |
S |
$5.30 |
$397,395 |
I/I |
(75,000) |
490,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
40,500 |
90,500 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-09 |
4 |
S |
$6.96 |
$447,117 |
I/I |
(64,276) |
565,032 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-08 |
4 |
S |
$7.01 |
$882,891 |
I/I |
(125,863) |
629,308 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-07 |
4 |
S |
$7.59 |
$691,180 |
I/I |
(91,031) |
755,171 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-04 |
4 |
S |
$7.70 |
$778,531 |
I/I |
(101,104) |
846,202 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-03 |
4 |
S |
$7.90 |
$277,027 |
I/I |
(35,060) |
947,306 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-01 |
4 |
AS |
$10.15 |
$81,161 |
D/D |
(8,000) |
50,000 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-02-01 |
4 |
OE |
$2.00 |
$16,000 |
D/D |
8,000 |
58,000 |
0 |
- |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-24 |
4 |
S |
$10.07 |
$936,412 |
I/I |
(88,055) |
982,366 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-21 |
4 |
S |
$10.51 |
$755,815 |
I/I |
(70,318) |
1,070,421 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-20 |
4 |
S |
$11.33 |
$1,277,289 |
I/I |
(112,767) |
1,140,739 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-19 |
4 |
AS |
$10.89 |
$756,092 |
I/I |
(69,414) |
1,253,506 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-18 |
4 |
AS |
$11.46 |
$4,584 |
I/I |
(400) |
1,322,920 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-18 |
4 |
AS |
$11.54 |
$92,314 |
D/D |
(8,000) |
50,000 |
0 |
% |
|
| YMAB |
Y-Mabs Therapeutics Inc |
See remarks |
• • – |
2022-01-18 |
4 |
OE |
$2.00 |
$16,000 |
D/D |
8,000 |
58,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
